Trials / Completed
CompletedNCT01001130
Regulatory AVAMYS Nasal Spray PMS
An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Effectiveness of Avamys® Administered in Korean Patients According to the Prescribing Information
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,244 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
Non-interventional, open-label, single group, multicentric post-marketing surveillance to monitor the safety and effectiveness of AVAMYS nasal spray administered in Korean patients according to the prescribing information. AVAMYS is a registered trademark of the GSK group of companies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluticasone furoate group | patients who are administered fluticasone furoate at least once |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2009-10-23
- Last updated
- 2014-06-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01001130. Inclusion in this directory is not an endorsement.